Northwestern University Human Resources
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
- Conditions
- Colorectal CancerConstipation, Impaction, and Bowel ObstructionGastric CancerGastrointestinal Carcinoid TumorGastrointestinal Stromal TumorQuality of LifeSmall Intestine Cancer
- First Posted Date
- 2003-05-14
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004911
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
- Conditions
- Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid TumorGastrointestinal Stromal TumorPancreatic CancerQuality of LifeSmall Intestine Cancer
- First Posted Date
- 2003-05-09
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004910
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Conditions
- Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant Condition
- First Posted Date
- 2003-05-09
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004232
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
- Conditions
- Ovarian CancerPancreatic CancerPeritoneal Cavity CancerColorectal CancerGastric CancerNausea and VomitingSmall Intestine CancerExtrahepatic Bile Duct CancerConstipation, Impaction, and Bowel ObstructionGastrointestinal Stromal Tumor
- First Posted Date
- 2003-05-09
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004895
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
- Conditions
- LymphomaBreast CancerLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic/Myeloproliferative Diseases
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00006225
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
- Conditions
- Kidney CancerBladder CancerBreast CancerColorectal CancerLung CancerPancreatic Cancer
- Interventions
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 38
- Registration Number
- NCT00004095
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma
- Conditions
- Liver Cancer
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 8
- Registration Number
- NCT00057980
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
- Conditions
- Head and Neck CancerLung Cancer
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00058006
- Locations
- 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸Rush Cancer Institute at Rush University Medical Center, Chicago, Illinois, United States
Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00057993
Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: filgrastimBiological: rituximabProcedure: peripheral blood stem cell transplantationRadiation: yttrium Y 90 ibritumomab tiuxetan
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 44
- Registration Number
- NCT00058292
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States